Integra Lifesciences Holdings Corp (IART)
23.27
-0.04
(-0.17%)
USD |
NASDAQ |
Nov 14, 16:00
23.27
0.00 (0.00%)
After-Hours: 20:00
Integra Lifesciences Holdings Free Cash Flow (Quarterly): -7.161M for Sept. 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -7.161M |
| June 30, 2024 | 10.69M |
| March 31, 2024 | 0.291M |
| December 31, 2023 | 34.22M |
| September 30, 2023 | 13.69M |
| June 30, 2023 | 12.73M |
| March 31, 2023 | 12.45M |
| December 31, 2022 | 70.88M |
| September 30, 2022 | 59.16M |
| June 30, 2022 | 57.07M |
| March 31, 2022 | 30.28M |
| December 31, 2021 | 41.79M |
| September 30, 2021 | 75.49M |
| June 30, 2021 | 84.66M |
| March 31, 2021 | 62.41M |
| December 31, 2020 | 51.84M |
| September 30, 2020 | 62.91M |
| June 30, 2020 | 25.90M |
| March 31, 2020 | -0.705M |
| December 31, 2019 | 66.99M |
| September 30, 2019 | -14.35M |
| June 30, 2019 | 30.86M |
| March 31, 2019 | 13.40M |
| December 31, 2018 | 17.00M |
| September 30, 2018 | 62.58M |
| Date | Value |
|---|---|
| June 30, 2018 | 16.21M |
| March 31, 2018 | 26.14M |
| December 31, 2017 | -2.148M |
| September 30, 2017 | 37.45M |
| June 30, 2017 | 16.05M |
| March 31, 2017 | 19.69M |
| December 31, 2016 | -14.66M |
| September 30, 2016 | 39.79M |
| June 30, 2016 | 29.81M |
| March 31, 2016 | 14.14M |
| December 31, 2015 | 12.54M |
| September 30, 2015 | 14.25M |
| June 30, 2015 | 18.36M |
| March 31, 2015 | 26.29M |
| December 31, 2014 | 13.15M |
| September 30, 2014 | 24.66M |
| June 30, 2014 | 7.021M |
| March 31, 2014 | -0.081M |
| December 31, 2013 | 7.117M |
| September 30, 2013 | 17.56M |
| June 30, 2013 | -10.70M |
| March 31, 2013 | -3.007M |
| December 31, 2012 | -28.08M |
| September 30, 2012 | 8.192M |
| June 30, 2012 | -11.95M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-7.161M
Minimum
Sep 2024
84.66M
Maximum
Jun 2021
38.28M
Average
38.00M
Median
Free Cash Flow (Quarterly) Benchmarks
| Boston Scientific Corp | 698.00M |
| ResMed Inc | 305.93M |
| Perspective Therapeutics Inc | -9.917M |
| Xtant Medical Holdings Inc | -5.652M |
| Catheter Precision Inc | -1.742M |